Want to see APEMY full AI Analyst Report?
Aperam SA (APEMY) AI Stock Analysis
Aperam SA
(Other OTC:APEMY)
The overall score reflects a company with recovering fundamentals and an attractive dividend yield, offset by extremely weak technical momentum. The strong revenue growth and solid balance sheet are the primary positives, but the stock is under severe selling pressure, trading at oversold levels below all key moving averages.
Aperam SA (APEMY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.83B
- Dividend Yield
- 6.13%
- Average Volume (3M)
- 752
- Price to Earnings (P/E)
- 19.4
- Beta (1Y)
- 1.09
- Revenue Growth
- 3.01%
- EPS Growth
- -30.47%
- Country
- US
- Employees
- 13,000
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Steel
Aperam SA Business Overview & Revenue Model
Company Description
Aperam S.A., along with its affiliated companies, operates globally as a manufacturer and vendor of stainless and specialized steel products. Its business activities are organized into three primary divisions: Stainless & Electrical Steel, Services &...
How the Company Makes Money
Aperam primarily makes money by manufacturing and selling steel products—especially stainless and specialty steels—to industrial and commercial customers. Revenue is generated mainly from (1) sales of stainless steel flat products (e.g., coils, sheet...
Aperam SA Earnings Call Summary
The call presents a mix of constructive company-specific progress and near-term market headwinds. Highlights include clear CapEx and investment plans (EUR 200m CapEx in 2026 and EUR 160m site upgrades over 3 years), an articulated Leadership Journey expected to add ~EUR 150m EBITDA (including Universal synergies), a stronger Q1/Q2 EBITDA run-rate (EUR 100m quarterly in H1), improved Brazil performance (EUR ~75m EBITDA) and flexible spare EAF capacity with a 7%–10% potential utilization uplift. Lowlights are primarily market-driven: a Q4 import surge created an H1 inventory overhang, CBAM/trade defense timing and importer behaviors remain uncertain (despite a planned 1 July start), a ~EUR 300/tonne margin gap versus historic averages, and limited forward visibility due to short order books (2.5 months). On balance, company fundamentals, clear targets, capacity to ramp and diversification into alloys/specialties give meaningful upside potential, while the lowlights represent industry and timing risks that management is actively addressing.
Q4-2025 Updates
Positive Updates
Negative Updates
Company Guidance
Management guidance: Q1 EBITDA is expected to be higher than Q4 with a ~EUR100m quarterly run‑rate across H1 2026 (slow start in Q1, ramp in Q2); normalized FY guidance is EUR700–800m (versus a prior ~EUR800m target), built from a 2025 baseline of EUR350m plus ~EUR150m from the Leadership Journey and ~EUR50m of announced investments (full effect by 2029), with the remaining EUR50–75m dependent on trade‑defense/CBAM recovery; CapEx is c. EUR200m in 2026 (including EUR160m of site upgrades over 3 years; continuity CapEx ~EUR150m); current capacity utilization is ~65–75% with safeguard measures expected to lift utilization 7–10%; Brazil delivered ~EUR75m EBITDA in 2025 (low cycle) and higher Brazilian duties (c.12.6%→25%) are expected to add mid‑single‑digit EUR EBITDA per quarter; A&S target ~EUR100m (+ ~EUR60m from Universal and ~EUR9m synergies) and R&R guidance remains around EUR80–85m; order books run ~2.5 months, Q4 import surge may create an H1 overhang, EU trade measures aim to start 1 July 2026, CBAM payments are retroactive to 2027, and nickel exposure is limited with fuel‑alloys positions fully hedged.
Aperam SA Financial Statement Overview
Summary
Revenue surged 58.4% TTM with gross margin improving to 25.2%, signaling a strong cyclical recovery. A solid balance sheet (D/E 0.41) and healthy cash generation (FCF $354M) provide stability, though net margins remain modest at ~2% and FCF declined 13% TTM.
Income Statement
60NeutralBalance Sheet
75PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.03B | 6.08B | 6.25B | 6.59B | 8.16B | 5.10B |
| Gross Profit | 1.74B | 341.00M | 449.00M | 330.00M | 1.18B | 1.23B |
| EBITDA | 362.52M | 247.00M | 354.00M | 364.00M | 960.00M | 1.20B |
| Net Income | 123.46M | 9.00M | 231.00M | 203.00M | 625.00M | 968.00M |
Balance Sheet | ||||||
| Total Assets | 6.78B | 6.21B | 5.84B | 6.21B | 6.26B | 5.91B |
| Cash, Cash Equivalents and Short-Term Investments | 334.00M | 324.86M | 216.00M | 443.00M | 457.00M | 524.00M |
| Total Debt | 1.33B | 1.30B | 760.00M | 934.00M | 925.00M | 990.00M |
| Total Liabilities | 3.49B | 3.00B | 2.47B | 2.76B | 2.87B | 2.96B |
| Stockholders Equity | 3.27B | 3.19B | 3.35B | 3.44B | 3.38B | 2.94B |
Cash Flow | ||||||
| Free Cash Flow | 354.26M | 273.75M | 125.00M | 170.00M | 346.00M | 398.00M |
| Operating Cash Flow | 479.05M | 405.34M | 280.00M | 471.00M | 642.00M | 550.00M |
| Investing Cash Flow | -172.21M | -565.75M | -155.00M | -303.00M | -297.00M | -183.00M |
| Financing Cash Flow | -209.13M | 267.99M | -336.00M | -152.00M | -419.00M | -197.00M |
Aperam SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For APEMY, the sentiment is Negative. The current price of 38.29 is below the 20-day moving average (MA) of 41.90, below the 50-day MA of 48.27, and below the 200-day MA of 49.07, indicating a bearish trend. The MACD of -2.70 indicates Positive momentum. The RSI at 25.40 is Positive, neither overbought nor oversold. The STOCH value of 10.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for APEMY.
Aperam SA Peers Comparison
Overall Rating
CRS68Neutral
APEMY59Neutral
MTUS56Neutral
PKX56Neutral
MT53Neutral
WS48Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | $14.02B | 24.83 | 26.93% | 0.28% | 10.21% | 38.28% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 59Neutral | $2.71B | 19.45 | 3.94% | 6.13% | 3.01% | -30.47% | |
| 56Neutral | $875.41M | 111.16 | 1.17% | ― | 16.12% | ― | |
| 56Neutral | $15.05B | 15.35 | 2.39% | 3.11% | -3.30% | 164.60% | |
| 53Neutral | $44.53B | 25.14 | 3.31% | 1.21% | 3.25% | -27.63% | |
| 48Neutral | $2.08B | -70.10 | -2.72% | 1.57% | 69.13% | -132.01% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| APEMY | Aperam | 38.29 | 5.02 | 15.10% | |
| MT | ArcelorMittal | 59.81 | 22.08 | 58.51% | |
| CRS | Carpenter Technology Corp | 283.08 | -27.03 | -8.72% | |
| PKX | Posco | 49.67 | -5.12 | -9.34% | |
| MTUS | Metallus Inc. | 21.12 | 3.35 | 18.85% | |
| WS | Worthington Steel, Inc. | 40.66 | 9.45 | 30.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 01, 2026